These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9493636)

  • 1. Failure of intravenous immunoglobulin to arrest progression of multiple sclerosis: a clinical and MRI based study.
    Francis GS; Freedman MS; Antel JP
    Mult Scler; 1997 Dec; 3(6):370-6. PubMed ID: 9493636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
    Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y
    Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS).
    Fazekas F; Sørensen PS; Filippi M; Ropele S; Lin X; Koelmel HW; Fernandez O; Pozzilli C; O'Connor P; Enriquez MM; Hommes OR;
    Mult Scler; 2005 Aug; 11(4):433-40. PubMed ID: 16042226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment effects of monthly intravenous immunoglobulin on patients with relapsing-remitting multiple sclerosis: further analyses of the Austrian Immunoglobulin in MS study.
    Fazekas F; Deisenhammer F; Strasser-Fuchs S; Nahler G; Mamoli B
    Mult Scler; 1997 Apr; 3(2):137-41. PubMed ID: 9291168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immune globulin in multiple sclerosis: clinical and neuroradiological results and implications for possible mechanisms of action.
    Achiron A; Barak Y; Goren M; Gabbay U; Miron S; Rotstein Z; Noy S; Sarova-Pinhas I
    Clin Exp Immunol; 1996 May; 104 Suppl 1():67-70. PubMed ID: 8625547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
    Sørensen PS
    Neurol Sci; 2003 Oct; 24 Suppl 4():S227-30. PubMed ID: 14598048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined immunoglobulin and azathioprine in multiple sclerosis.
    Kalanie H; Tabatabai SS
    Eur Neurol; 1998; 39(3):178-81. PubMed ID: 9605396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, cross-over trial of intravenous immunoglobulin G in multiple sclerosis: preliminary results.
    Sørensen PS; Wanscher B; Schreiber K; Blinkenberg M; Jensen CV; Ravnborg M
    Mult Scler; 1997 Apr; 3(2):145-8. PubMed ID: 9291170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies.
    McFarland HF; Stone LA; Calabresi PA; Maloni H; Bash CN; Frank JA
    Mult Scler; 1996 Nov; 2(4):198-205. PubMed ID: 9345374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: interferon beta for some serious forms.
    Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
    Soelberg Sorensen P
    Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
    Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
    Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].
    Staffen W; Trinka E; Ladurner G
    Nervenarzt; 1993 Apr; 64(4):226-32. PubMed ID: 8506010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI of multiple sclerosis in Thai patients.
    Chawalparit O; Prayoonwiwat N
    J Med Assoc Thai; 2006 Apr; 89(4):422-7. PubMed ID: 16696384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial.
    Hommes OR; Sørensen PS; Fazekas F; Enriquez MM; Koelmel HW; Fernandez O; Pozzilli C; O'Connor P
    Lancet; 2004 Sep 25-Oct 1; 364(9440):1149-56. PubMed ID: 15451222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multiple sclerosis: characteristics and management.
    Hawker K
    Neurol Clin; 2011 May; 29(2):423-34. PubMed ID: 21439451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis.
    Stone LA; Frank JA; Albert PS; Bash C; Smith ME; Maloni H; McFarland HF
    Ann Neurol; 1995 May; 37(5):611-9. PubMed ID: 7755356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin, plasmalymphocytapheresis and azathioprine in chronic progressive multiple sclerosis.
    Uccelli A; Capello E; Fenoglio D; Incagliato M; Valbonesi M; Mancardi GL
    Ital J Neurol Sci; 1994 Feb; 15(1):51-3. PubMed ID: 8206747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis.
    Filippi M; Rocca MA; Pagani E; Iannucci G; Sormani MP; Fazekas F; Ropele S; Hommes OR; Comi G
    Arch Neurol; 2004 Sep; 61(9):1409-12. PubMed ID: 15364687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.